These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34493350)

  • 21. [Myelin oligodendrocyte glycoprotein immunoglobulin G-associated encephalomyelitis].
    Eliseeva DD; Vasiliev AV; Shabalina AA; Simaniv TO; Zakharova MN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):13-23. PubMed ID: 32844625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children.
    Hou C; Wu W; Tian Y; Zhang Y; Zhu H; Zeng Y; Peng B; Zheng K; Li X; Chen W
    Mult Scler Relat Disord; 2020 Jul; 42():102018. PubMed ID: 32234601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and imaging features of children with autoimmune encephalitis and MOG antibodies.
    Wegener-Panzer A; Cleaveland R; Wendel EM; Baumann M; Bertolini A; Häusler M; Knierim E; Reiter-Fink E; Breu M; Sönmez Ö; Della Marina A; Peters R; Lechner C; Piepkorn M; Roll C; Höftberger R; Leypoldt F; Reindl M; Rostásy K
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32358225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome.
    Mariotto S; Monaco S; Peschl P; Coledan I; Mazzi R; Höftberger R; Reindl M; Ferrari S
    BMC Neurol; 2017 Oct; 17(1):190. PubMed ID: 28982346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
    Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
    Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unilateral cerebral cortical encephalitis with epilepsy: a possible special phenotype of MOG antibody-associated disorders.
    Tao R; Qin C; Chen M; Yu HH; Wu LJ; Bu BT; Tian DS
    Int J Neurosci; 2020 Nov; 130(11):1161-1165. PubMed ID: 31971044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Spontaneous Model of Experimental Autoimmune Encephalomyelitis Provides Evidence of MOG-Specific B Cell Recruitment and Clonal Expansion.
    Salvador F; Deramoudt L; Leprêtre F; Figeac M; Guerrier T; Boucher J; Bas M; Journiac N; Peters A; Mars LT; Zéphir H
    Front Immunol; 2022; 13():755900. PubMed ID: 35185870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
    Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
    Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
    Ramanathan S; Dale RC; Brilot F
    Autoimmun Rev; 2016 Apr; 15(4):307-24. PubMed ID: 26708342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of assaying anti-MOG antibody in cerebrospinal fluid in MOG-antibody-associated diseases: A case report.
    Aoe S; Kume K; Takata T; Touge T; Kaneko K; Nakashima I; Deguchi K; Masaki T
    Mult Scler Relat Disord; 2019 Feb; 28():165-166. PubMed ID: 30605793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays.
    Tzartos JS; Karagiorgou K; Tzanetakos D; Breza M; Evangelopoulos ME; Pelidou SH; Bakirtzis C; Nikolaidis I; Koutsis G; Notas K; Chroni E; Markakis I; Grigoriadis NC; Anagnostouli M; Orologas A; Parisis D; Karapanayiotides T; Papadimitriou D; Kostadima V; Elloul J; Xidakis I; Maris T; Zisimopoulou P; Tzartos S; Kilidireas C
    J Neurol Sci; 2020 Mar; 410():116673. PubMed ID: 31954354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical observation on the overlapping syndrome of myelin oligodendrocyte glycoprotein antibody and anti-N-methyl-D aspartate receptor in children].
    Gong S; Zhang WH; Ren HT; Li JW; Zhou J; Cheng H; Zhuo XW; Ren CH; Han TL; Lyu JL; Ding CH; Fang F; Guan HZ; Ren XT
    Zhonghua Er Ke Za Zhi; 2020 Jul; 58(7):581-585. PubMed ID: 32605343
    [No Abstract]   [Full Text] [Related]  

  • 36. 'Leukodystrophy-like' phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disease.
    Hacohen Y; Rossor T; Mankad K; Chong W'; Lux A; Wassmer E; Lim M; Barkhof F; Ciccarelli O; Hemingway C
    Dev Med Child Neurol; 2018 Apr; 60(4):417-423. PubMed ID: 29288492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein (MOG) antibody].
    Adachi H; Ide Y; Takahashi T; Yoneda Y; Kageyama Y
    Rinsho Shinkeigaku; 2018 Dec; 58(12):767-770. PubMed ID: 30487364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child.
    Sarigecili E; Cobanogullari MD; Komur M; Okuyaz C
    Mult Scler Relat Disord; 2019 Feb; 28():101-103. PubMed ID: 30590238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation.
    Loos J; Pfeuffer S; Pape K; Ruck T; Luessi F; Spreer A; Zipp F; Meuth SG; Bittner S
    J Neurol; 2020 Jun; 267(6):1632-1642. PubMed ID: 32055995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.